New polymeric carriers for controlled drug delivery following inhalation or injection

Biomaterials

Volumn 23, Issue 22, 2002, Pages 4425-4433

  Fu, Jie ^a   Fiegel, Jennifer ^a   Krauland, Eric ^b   Hanes, Justin ^a,b  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

Author keywords

Biodegradable polymers; Controlled release; Inhalation; Lung; Pulmonary drug delivery

Indexed keywords

INHALATION;

COPOLYMERS; DRUG DOSAGE; POLYETHYLENE GLYCOLS; POROUS MATERIALS; TISSUE;

BIOMATERIALS;

COPOLYMER; MACROGOL; MONOMER; POLYMER; SEBACIC ACID;

AEROSOL; ARTICLE; BIODEGRADABILITY; DRUG DELIVERY SYSTEM; DRY POWDER; INHALATION; INJECTION; LUNG; MOLECULAR WEIGHT; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; SOLUBILITY; SURFACE PROPERTY; SYNTHESIS;

ADMINISTRATION, INHALATION; ANHYDRIDES; BIOCOMPATIBLE MATERIALS; DECANOIC ACIDS; DICARBOXYLIC ACIDS; DRUG DELIVERY SYSTEMS; ETHERS; INJECTIONS; KINETICS; LUNG; MAGNETIC RESONANCE SPECTROSCOPY; PHAGOCYTOSIS; POLYETHYLENE GLYCOLS; POLYMERS; TIME FACTORS;

EID: 0036345152     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00182-5     Document Type: Article

References (50)

1. Drug delivery and targeting
2. Pulmonary absorption of peptides and proteins
3. Pulmonary delivery of powder and solutions containing granulocyte colony-stimulating factor (rhg-CSF) after intratracheal instillation to the hamster
4. Pulmonary delivery of peptides and proteins for systemic action
5. The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes
6. Mechanisms of macromolecule absorption by the lungs
7. Inhalation of estradiol for sustained systemic delivery
8. Inhalation delivery of proteins from ethanol suspensions
9. The lung as a route for systemic delivery of therapeutic proteins and peptides
10. Aerosol delivery of muramyl dipeptide to rodent lungs
11. Deep-lung delivery of therapeutic proteins
12. The cost of delivering drugs without needles
13. Inhaled insulin: Clinical results in type 2 diabetic patients
14. Inhaled insulin
15. Pulmonary delivery of drugs for bone disorders
16. Physiology and pharmacology of the airways
17. Permeability of the respiratory tract to different-sized macromolecules after intratracheal instillation in young and adult rats
18. Bioavailability of pulmonary delivered peptides and proteins: Α-interferon, calcitonins and parathyroid hormones
19. Inhalation: The other "oral" route for delivery of molecules with low gastrointestinal bioavailability
20. Recent advances in pulmonary drug delivery using large, porous inhaled particles
21. The controlled delivery of drugs to the lung
22. Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers
23. New approaches for managing influenza in primary care
24. Treating systemic diseases via the lung
25. Large porous particles for pulmonary drug delivery
26. Pulmonary delivery of free and liposomal insulin
27. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Screening in an infectious disease model
28. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Manufacture and characterization
29. Histidylated polylysine as a synthetic vector for gene transfer into immortalized cystic fibrosis airway surface and airway gland serous cells
30. Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs
31. Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes
32. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy
33. Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres
34. A theoretical model of erosion and macromolecular drug release from biodegrading microspheres
35. Non-invasive in vivo characterization of release processes in biodegradable polymers by low-frequency electron paramagnetic resonance spectroscopy
36. Erosion of a new family of biodegradable Polyanhydrides
37. Vanderwaals and other cohesive forces affecting powder fluidization
38. Effect of the size and surface-charge of polymer microspheres on their phagocytosis by macrophage
39. Biodegradable long-circulating polymeric nanospheres
40. Large, light polyether-anhydride microspheres: A new carrier for pulmonary drug delivery
41. On the removal of air-borne droplets by the human respiratory tract. I
42. Aerosol dispersion in human lung: Comparison between numerical simulations and experiments for bolus tests
43. Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery
44. Tetrandrine delivery to the lung: The optimization of albumin microsphere preparation by central composite design
45. Air-interfaced lung epithelial cell monolayers for characterization of large light polymer aerosols